Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study
Yajun He(The First People's Hospital of Shunde), Jie Shen(Xinjiang Medical University), Feng Tian(The First People's Hospital of Shunde), Lin Xu(Northeast Agricultural University), Genfeng Yu(The First People's Hospital of Shunde), Xingying Chen(Henan Polytechnic University), Hualin Duan(The First People's Hospital of Shunde), Dongmei Wang(Changzhou No.2 People's Hospital), Lan Liu(Kunming University of Science and Technology), Lingling Liu(The First People's Hospital of Shunde), Heng Wan(The First People's Hospital of Shunde), Nanfang Yao, Yuqi Jiang(The First People's Hospital of Shunde), Qintao Ma(The First People's Hospital of Shunde), Cheng Song(The First People's Hospital of Shunde)
Cited by 28
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
<p>Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration</p>
|International Journal of Nanomedicine|2020|521
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health
|Clinical Interventions in Aging|2018|193